$AMGN · Amgen Inc.
Amgen Inc. filed a Form 4 with the SEC reporting a change in beneficial ownership by director Charles M. Holley. On November 6, 2026, Holley acquired 184.614 shares of Amgen common stock at a price of $0. The shares resulted from the vesting of restricted stock units granted under the Amgen Inc. 2009 Director Equity Incentive Program, as amended, under the company’s Second Amended and Restated 2009 Equity Incentive Plan. The restricted stock units vested immediately and are paid in common stock on a one-to-one basis, though a director may elect to defer payment.
Following the reported transaction, Holley directly beneficially owned 13,262.066 shares of Amgen common stock. The filing also notes that this total includes 1,739 dividend equivalents credited to unvested restricted stock units under a qualifying dividend reinvestment plan. Those dividend equivalents are paid out in shares on a one-to-one basis according to the vesting schedule, with any fractional share amount paid in cash. In addition, Holley indirectly held 1,260 shares through the Holley Family Trust.